OraSure Technologies Inc. Common Stock
OSURUnited States
5 filed reports · 295 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 862 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 827 | Dec 2025 |
Financial data
295 concepts · 1,689 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial292 concepts · 1,604 facts · Sep 2023 to Jun 2026
- Stockholders equity (US GAAP)14 · Dec 2023 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value13 · Dec 2023 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations13 · Dec 2023 to Jun 2026
- Net income loss13 · Dec 2023 to Jun 2026
- Other comprehensive income loss foreign currency transaction and translation adjustment net of tax13 · Dec 2023 to Jun 2026
- Stock repurchased and retired during period value13 · Dec 2023 to Jun 2026
- Allocated share based compensation expense12 · Dec 2023 to Jun 2026
- Comprehensive income net of tax12 · Dec 2023 to Jun 2026
- Cost of goods and services sold (US GAAP)12 · Dec 2023 to Jun 2026
- Depreciation depletion and amortization12 · Dec 2023 to Jun 2026
- Foreign currency transaction gain loss before tax12 · Dec 2023 to Jun 2026
- Gain loss on disposition of assets112 · Dec 2023 to Jun 2026
- General and administrative expense (US GAAP)12 · Dec 2023 to Jun 2026
- Gross profit (US GAAP)12 · Dec 2023 to Jun 2026
- Income loss from equity method investments12 · Dec 2023 to Jun 2026
- Income tax expense benefit12 · Dec 2023 to Jun 2026
- Investment income interest12 · Dec 2023 to Jun 2026
- Operating expenses (US GAAP)12 · Dec 2023 to Jun 2026
- Operating income loss12 · Dec 2023 to Jun 2026
- Other nonoperating income12 · Dec 2023 to Jun 2026
- Other nonoperating income expense12 · Dec 2023 to Jun 2026
- Research and development expense12 · Dec 2023 to Jun 2026
- Revenue12 · Dec 2023 to Jun 2026
- Segment reporting other item amount12 · Dec 2023 to Jun 2026
Geography1 concepts · 48 facts · Dec 2023 to Jun 2026
- Revenue48 · Dec 2023 to Jun 2026
Product2 concepts · 37 facts · Dec 2023 to Jun 2026
- Revenue36 · Dec 2023 to Jun 2026
- Other nonoperating income expense1 · Dec 2023
Segments
85 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement geographical4 members · 48 facts
- Africa12 · Dec 2023 to Jun 2026
- Europe12 · Dec 2023 to Jun 2026
- Other Foreign Countries12 · Dec 2023 to Jun 2026
- US12 · Dec 2023 to Jun 2026
Product or service9 members · 37 facts
- Other Revenues12 · Dec 2023 to Jun 2026
- Product And Services12 · Dec 2023 to Jun 2026
- COVID192 · Jun 2025 to Jun 2026
- Hcv2 · Jun 2025 to Jun 2026
- Hiv2 · Jun 2025 to Jun 2026
- Molecular Products2 · Jun 2025 to Jun 2026
- Other Product And Services Revenues2 · Jun 2025 to Jun 2026
- Risk Assessment Testing2 · Jun 2025 to Jun 2026
- Government Contract1 · Dec 2023
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Nov 2025 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 5, 2026
- FY2026 Q1May 6, 2026
- FY2025 Q4Feb 25, 2026
- FY2025 Q3Nov 5, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.